4073 Results

People

  1. Hudis
    Hudis
  2. Giralt
    Giralt
  3. Gonen
    Gonen
  4. Levine
    Levine
  5. Scher
    Scher
  6. Fong
    Fong
  7. Motzer
    Motzer
  8. Ladanyi
    Ladanyi
  9. Travis
    Travis
  10. Jarnagin
    Jarnagin

Groups

  1. Department of Medicine (1421)
  2. GSK Faculty (1000)
  3. Surgery (873)
  4. Solid Tumor Oncology Division (781)
  5. Survivorship Research (671)
  6. Sloan Kettering Institute Faculty (646)
  7. Department of Pathology and Laboratory Medicine (556)
  8. Center for Hematologic Malignancies (550)
  9. Hematologic Malignancies, Division of (465)
  10. Epidemiology and Biostatistics (464)
  1. "2013"
Formats
  1. Journal Article (2495)
  2. Meeting Abstract (1292)
  3. Book Section (250)
  4. Conference Paper (18)
  5. Book Whole (17)
  6. Review (1)
Groups
  1. Department of Medicine (1421)
  2. GSK Faculty (1000)
  3. Surgery (873)
  4. Solid Tumor Oncology Division (781)
  5. Survivorship Research (671)
  6. Sloan Kettering Institute Faculty (646)

More Groups

People
  1. Jose Baselga (74)
  2. Clifford Hudis (69)
  3. Jedd Wolchok (65)
  4. Howard Scher (62)
  5. Mithat Gonen (62)
  6. Ross Levine (62)

More People

Years
  1. 2013 (4073)
Publications
  1. Journal of Clinical Oncology (366)
  2. Blood (190)
  3. Cancer Research (119)
  4. International Journal of Radiation Oncology, Biology, Physics (88)
  5. Modern Pathology (88)
  6. Laboratory Investigation (81)

More Publications

Publishers
  1. Elsevier Inc. (502)
  2. American Society of Clinical Oncology (386)
  3. Springer (304)
  4. Nature Publishing Group (249)
  5. Elsevier Science, Inc. (206)
  6. American Society of Hematology (192)

More Publishers

Results (4073)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase Ib clinical trial of the multitargeted kinase inhibitor lenvatinib (E7080) in combination with everolimus for treatment of metastatic renal cell carcinoma (RCC)
    Meeting Abstract

    Molina, A. M.; Hutson, T. E.; Larkin, J. M. G.; Gold, A.; Andresen, C.; Wood, K.; Motzer, R. J.; Michaelson, M. D.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Efficacy and safety data from patients with advanced renal cell cancer treated with tivozanib hydrochloride after progression on sorafenib
    Meeting Abstract

    Motzer, R. J.; Nosov, D.; Tomczak, P.; Berkenblit, A.; Esteves, B.; Strahs, A. L.; Hutson, T. E.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Effect of enzalutamide on health-related quality of life (HRQoL) in men with metastatic castration-resistant prostate cancer (mCRPC) following docetaxel-based therapy: Results from the AFFIRM study
    Meeting Abstract

    Miller, K.; Scher, H. I.; Fizazi, K.; Basch, E. M.; Sternberg, C. N.; Hirmand, M.; Cella, D.; Ivanescu, C.; Phung, D.; Spalding, J. R.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Phase I trial of zirconium 89 (Zr89) radiolabeled J591 in metastatic castration-resistant prostate cancer (mCRPC)
    Meeting Abstract

    Morris, M. J.; Pandit-Taskar, N.; Carrasquillo, J. A.; O'Donoghue, J. A.; Humm, J.; Lyashchenko, S. K.; Haupt, E. C.; Bander, N. H.; Tagawa, S. T.; Holland, J. P.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Surveillance for the management of small renal masses: Utilization and outcomes in a population-based cohort
    Meeting Abstract

    Huang, W. C.; Pinheiro, L. C.; Russo, P.; Lowrance, W. T.; Elkin, E. B.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Relationship of ERCC1 genotype variant with mRNA expression and ERCC1 protein levels in advanced urothelial carcinoma (UC)
    Meeting Abstract

    Guancial, E. A.; Werner, L.; Bellmunt, J.; Nikitas, N.; Stack, E. C.; Lis, R.; Signoretti, S.; Loda, M.; Regan, M. M.; Park, R. S.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Comparison of PFS and safety for Asian compared to North American and European populations in the phase III trial of pazopanib versus sunitinib in patients with treatment-naive RCC (COMPARZ)
    Meeting Abstract

    Guo, J.; Jin, J.; Huang, Y.; Wang, J. W.; Lim, H. Y.; Uemura, H.; Rha, S. Y.; Wu, H. C.; Crescenzo, R.; Deen, K. C.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Subgroup analyses of a phase III trial comparing tivozanib hydrochloride versus sorafenib as initial targeted therapy for patients (pts) with metastatic renal cell carcinoma (mRCC)
    Meeting Abstract

    Hutson, T. E.; Nosov, D.; Eisen, T.; Lipatov, O. N.; Tomczak, P.; Alyasova, A.; Harza, M.; Kogan, M.; Alexseev, B. Y.; Szczylik, C.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • MicroRNA as novel blood-based biomarkers in clear cell renal cell carcinoma
    Meeting Abstract

    Hakimi, A. A.; Jacobsen, A.; Mikkilineni, N.; Fiegoli, B.; Blass, S.; Grigoryev, Y.; Viale, A.; Socci, N. D.; Voss, M. H.; Motzer, R. J.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Global metabolic profiling of clear cell renal cell carcinoma
    Meeting Abstract

    Hakimi, A. A.; Lee, C. H.; Cross, J. R.; Li, Z.; Chen, Y.; Neri, B.; Reuter, V. E.; Motzer, R. J.; Russo, P.; Hsieh, J.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save